DK0635004T3 - 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf - Google Patents

4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0635004T3
DK0635004T3 DK93907333T DK93907333T DK0635004T3 DK 0635004 T3 DK0635004 T3 DK 0635004T3 DK 93907333 T DK93907333 T DK 93907333T DK 93907333 T DK93907333 T DK 93907333T DK 0635004 T3 DK0635004 T3 DK 0635004T3
Authority
DK
Denmark
Prior art keywords
preparation
diphenylmethylpiperidine
derivatives
diphenylmethylpiperidine derivatives
Prior art date
Application number
DK93907333T
Other languages
Danish (da)
English (en)
Inventor
Chi-Hsin Richard King
Michele A Kaminski
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0635004T3 publication Critical patent/DK0635004T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93907333T 1992-04-10 1993-03-10 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf DK0635004T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86726192A 1992-04-10 1992-04-10
US1725193A 1993-02-25 1993-02-25
PCT/US1993/002103 WO1993021156A1 (en) 1992-04-10 1993-03-10 4-diphenylmethyl piperidine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
DK0635004T3 true DK0635004T3 (da) 2002-11-11

Family

ID=26689638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907333T DK0635004T3 (da) 1992-04-10 1993-03-10 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
EP (1) EP0635004B1 (sv)
JP (3) JP3686950B2 (sv)
KR (1) KR100257805B1 (sv)
AR (1) AR253777A1 (sv)
AT (1) ATE220666T1 (sv)
AU (1) AU671822B2 (sv)
CA (1) CA2117892C (sv)
DE (1) DE69332117T2 (sv)
DK (1) DK0635004T3 (sv)
ES (1) ES2176201T3 (sv)
FI (2) FI106454B (sv)
HU (1) HU226561B1 (sv)
IL (1) IL105328A (sv)
MX (1) MX9302076A (sv)
NO (5) NO305076B1 (sv)
NZ (1) NZ251132A (sv)
PT (1) PT635004E (sv)
TW (1) TW362096B (sv)
WO (1) WO1993021156A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003170A1 (en) * 1992-08-03 1994-02-17 Sepracor Inc. Terfenadine metabolites and their optically pure isomers for treating allergic disorders
PT1026147E (pt) * 1993-06-24 2004-04-30 Albany Molecular Res Inc Compostos uteis como intermediarios na producao de derivados de piperidina
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
CN1275916C (zh) 1993-06-25 2006-09-20 阿温蒂斯公司 用于制备抗组胺哌啶衍生物的新中间体
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
EP1178041A1 (en) * 1994-05-18 2002-02-06 Aventis Pharmaceuticals Inc. Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives
DK0812195T3 (da) 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
NZ508477A (en) * 1998-07-02 2003-12-19 Aventis Pharma Inc Antihistaminic piperidine derivatives and intermediates
SK13822003A3 (sk) * 2001-04-09 2004-09-08 Teva Pharmaceutical Industries Ltd. Polymorfné formy chloridu fexofenadínu
ITRM20010260A1 (it) 2001-05-17 2002-11-18 Dinamite Dipharma S P A In For Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz
US6743941B2 (en) * 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
WO2003104197A1 (en) 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20070987A1 (it) 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives

Also Published As

Publication number Publication date
NO305025B1 (no) 1999-03-22
AU671822B2 (en) 1996-09-12
WO1993021156A1 (en) 1993-10-28
FI20002460A (sv) 2000-11-09
NO305023B1 (no) 1999-03-22
FI944713A (sv) 1994-12-02
NO305024B1 (no) 1999-03-22
JP3686950B2 (ja) 2005-08-24
JP2004285072A (ja) 2004-10-14
HU226561B1 (en) 2009-04-28
NO981433D0 (no) 1998-03-30
NO981432D0 (no) 1998-03-30
HU9402913D0 (en) 1995-01-30
NO981432L (no) 1994-12-09
NO943794L (no) 1994-12-09
NO305076B1 (no) 1999-03-29
HUT70517A (en) 1995-10-30
MX9302076A (es) 1994-03-31
CA2117892C (en) 2001-12-18
ATE220666T1 (de) 2002-08-15
NO981434L (no) 1994-12-09
JP2005213268A (ja) 2005-08-11
AU3797393A (en) 1993-11-18
DE69332117D1 (de) 2002-08-22
CA2117892A1 (en) 1993-10-28
NZ251132A (en) 1996-12-20
ES2176201T3 (es) 2002-12-01
IL105328A0 (en) 1993-08-18
TW362096B (en) 1999-06-21
PT635004E (pt) 2002-12-31
NO943794D0 (no) 1994-10-07
NO981434D0 (no) 1998-03-30
JPH08502022A (ja) 1996-03-05
NO981431D0 (no) 1998-03-30
JP4266184B2 (ja) 2009-05-20
KR950700881A (ko) 1995-02-20
EP0635004A1 (en) 1995-01-25
EP0635004B1 (en) 2002-07-17
AR253777A1 (es) 2001-10-08
DE69332117T2 (de) 2003-01-30
FI944713A0 (sv) 1994-10-07
NO981431L (no) 1994-12-09
FI106454B (sv) 2001-02-15
NO981433L (no) 1994-12-09
NO305077B1 (no) 1999-03-29
IL105328A (en) 2007-03-08
KR100257805B1 (ko) 2000-07-01

Similar Documents

Publication Publication Date Title
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NO931326D0 (no) Komposittprodukt og fremgangsmaate til fremstilling derav
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
NO973836D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
IS3555A7 (is) Pyrrol-afleiður og aðferð til framleiðslu þeirra
DK0380248T4 (da) Modificeret polydextrose og fremgangsmåde til fremstilling deraf
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
DK69989A (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK0579095T3 (da) Foderstoffer og fremgangsmåde til fremstilling deraf
DK1693D0 (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
NO964551D0 (no) Imidazolderivater og fremgangsmåte for fremstilling av slike
NO172472C (no) For og fremgangsmaate til fremstilling derav
DK0565105T3 (da) Forgrenede cyclodextriner og fremgangsmåder til fremstilling heraf
DK374089D0 (da) Il-1alfa-derivater og medkiament til behandling af thrombocytopenia
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
DK0492667T3 (da) 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf